Augmentin 875 mg+125 mg filmom obložene tablete
| Name | Augmentin 875 mg+125 mg filmom obložene tablete |
|---|---|
| Former Name | Augmentin 1 g filmom obložene tablete |
| Marketing Authorisation Number | HR-H-170450439 |
| Active Substance | amoksicilin trihidrat kalijev klavulanat |
| Composition | svaka filmom obložena tableta sadrži 875 mg amoksicilina u obliku amoksicilin trihidrata i 125 mg klavulanske kiseline u obliku kalijevog klavulanata |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Glaxo Wellcome Production, Mayenne, Francuska |
| Marketing Authorisation Holder | GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date | 20.08.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/15-02/456 |
| Registration Number | 381-12-01/70-21-39 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | neponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J01CR02 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
